There are two parts of a report that need to be analyzed and then discussed about the regulations, procedures, risks, and structure of a biotech company. Please find any flaws or add ons that can be mentioned/brought to the forefront for this discussion. Attached are three parts of the report broken into three groups. Discuss any two reports while telling which one you are responding to. You may refer to the pdf to get guidance for the risk management guidance.
